Summary. Adenylate cyclase activity was determined using a purified plasma membrane fraction prepared from isolated adipocytes by a Percoll gradient centrifugation procedure. The activation of adenylate cyclase by isoprenaline was reduced by approximately 50% in membranes from obese mice, although no reduction in the sensitivity of the response was apparent. Basal and fluoride-and 5'-guanylyl-imidodiphosphate-stimulated activities were similar in both groups. However, two defects in the obese system were identified which suggested that an alteration in the properties of the regulatory protein may account for the impaired hormonal activation. The specific binding of 3H-dihydroalprenalol to membranes from obese animals also was decreased, suggesting a reduction in the number of fl-adrenergic receptors.
The stimulation of adenylate cyclase by fl-adrenergic agonists is impaired in white adipose tissue from the genetically obese (ob/ob) mouse [1] [2] [3] [4] [5] . This mechanism is just one of a range of membrane-related processes which have been shown to be defective in the ob/ob mouse; others include brown fat thermogenesis [6] , hepatic (Na + + K +) ATPase [7] and glucose transport [8] . We have suggested that these defects may be related to lipid compositional changes in the membranes of ob/ ob mice [9, 10] .
The hormonal stimulation of cyclic AMP production involves an ordered series of interactions between three district membrane proteins, the fl-receptor, the regulatory protein, and the catalytic unit of adenylate cyclase [11] . Previous studies using relatively crude membrane preparations have suggested that a defect in the coupling process between the hormone receptor and the regulatory protein may be the basis for impaired isoprenaline stimulation of adenylate cyclase in membranes from ob/ob animals [3] [4] [5] . In this study we have used a purified epididymal adipocyte plasma membrane fraction to compare the regulation of adenylate cyclase and fl-receptor binding in membranes from lean and obese mice.
Materials and methods

Materials
[2-8-3H] Adenosine 3',5' cyclic phosphate (spec. act. 40 Ci/mmol) and l[propyl-2,3-3H] dihydroalprenalol (spec. act. 52 Ci/mmol) were obtained from Amersham International, Bucks, UK. Collagenase (Type I) was from Worthington Biochemicals, New Jersey, USA. Percoll was from Pharmacia Fine Chemicals, London, UK. Creatine phosphate, creatine kinase, cyclic AMP, (-) isoprenaline, 5'-guanylylimidodiphosphate (Gpp(NH)p), GTP and bacitracin were from Sigma, Poole, Dorset, UK and Synperonic NXP was from Cargo Fleet Chemicals, Middlesbrough, UK.
Animals
Lean (+/.9) and obese (ob/ob) mice (non-defined genetic background, but originating from the Aston strain, Birmingham University, Birmingham, UK), aged 8-10 weeks and bred in the Department's animal facility, were used in the experiments. The housing temperature was 24 ~ with a constant light-dark cycle (07.00-07.00 h).
Preparations of purified adipocyte plasma membranes
Animals were killed by cervical dislocation and the epididymal fat pads removed. Fat pads from ten lean or six obese animals were pooled and adipocytes were prepared by the collagenase digestion procedure described by Rodbell [12] , using I mg/ml collagenase and incubating at 37 ~ with gentle shaking. The isolated adipocytes were broken by homogenisation at 25 ~ in four volumes of buffer A (Tris-HC1 (10 mmol/1), sucrose (0.25 mol/1), EDTA (1 mmol/1), pH 7.4 at 4 ~ containing bacitracin (1 mg/ml). Six up and down strokes of a loose fitting pestle were employed at speed setting 2.5 (-2,500 rev/ min) on a Tri-R-Stir-R tissue homogenizer (Tri-R Instruments, Rockville Centre, New York, USA). The crude homogenate was defatted by centrifugation at room temperature at 2,000 rev/min for 30 s in a bench centrifuge. All subsequent operations were at 0~ ~ The defatted homogenate was centrifuged at 16,000 g for 15 min in the 8 x 50 fixed angle rotor of an MSE Hi-Spin 21 centrifuge (MSE Scientific Instruments, Crawley, Sussex, UK). The supernatant was discarded and the 16,000 g pellet resuspended in 5 ml buffer A. This crude plasma membrane fraction was further purified by Percoll gradient centrifugation as described by Belsham et al. [13] . Percoll was mixed with buffer A and a buffer containing Tris-HC1 (20 mmol/ 1), sucrose (2 mol/1) and EDTA (2 mmol/1) in the proportions 7 : 32 : 1 (by vol). The membrane suspension was dispersed in 40 ml of this Percoll solution, and the mixture centrifuged at 16,000 g for 20 min in the fixed angle rotor. The Percoll solution forms a density gradient during centrifugation and the purified plasma membrane fraction collects just below the surface of the gradient. This fraction was removed in a volume of -5 ml, washed by diluting to 45 ml with buffer A and harvested by centrifugation at 30,000 g for 20 rain in the fixed angle rotor. The pellet was resuspended in buffer A to give a final concentration of 1-2 mg/ml and stored at -70 ~ under nitrogen.
Assay of adenylate cyclase activity
Adenylate cyclase activity was assayed as described by Houslay et al. [14] , except that the regenerating system consisted of creatine phosphate (20 mmol/1) and creatine kinase (20 U/ml). Aliquots of the supernatant were assayed for cyclic AMP by the adrenal receptor assay of Brown et al. [15] .
Assay of 3H-dihydroalprenalol binding to adipocyte plasma membranes
Aliquots of purified plasma membrane (150-200 ~g) were incubated with 3H-dihydroalprenalol (1-10 nmol/l) in a reaction mixture (1 ml) containing Tris-HC1 (50 mmol/1), pH 7.8, and Mg C12 (20 mmol/1), either in the presence or absence of a 1,000-fold excess of (-) isoprenaline (100 ~tmol/1). The tubes were incubated for 30 min at 30 ~ The reaction was terminated by vacuum filtration on Whatman GF/C glass fibre filters and the filters were washed with 12 ml of ice-cold Tris-MgC12 buffer. Filtration and washing took <10s. The filters were placed in scintillation vials and the radioactivity eluted with 0.5 ml, 2% sodium dodecyl sulphate for 1 h and counted in 5 ml Tritoscint scintillation fluid (151 xylene; 7.51 synperonic NXP; 90g PPO; 6.75 g dimethyl-POPOP).
Enzyme assays
5'-nucleotidase (E. C. 3.1.3.5) was assayed as described by Avruch and Wallach [16] . Succinate-cytochrome c reductase was estimated as described by Tisdale [17] .
Protein determinations
Protein was determined by the method of Lowry et al. [18] or Bradford [19] , using bovine serum albumin as standard.
Statistical analysis was by the Student's t-test.
Results
Analysis of the purified plasma membrane preparations
It was necessary to establish that the Percoll gradient procedure afforded comparable purification of plasma membranes from lean and obese mice. Table 1 shows details of the activities of plasma membrane 5'-nucleotidase and mitochondrial succinate-cytochrome c reductase marker enzymes in both the crude 16,000 g pellet, obtained after disruption of the isolated adipocytes, and the purified fraction. 5'-nucleotidase activity was consistently lower in the membrane fractions obtained from obese animals, confirming a previous report [2] . However, on t-he basis of 5'-nucleotidase activity, the Percoll gradient procedure resulted in a similar level of purification and recovery of plasma membranes from lean and obese animals. Analysis of succinate cytochrome c reductase activity indicated a slightly higher level of mitochondrial contamination in the plasma membrane fraction from obese animals, but the recovery of activity in this fraction was low.
A comparison of the stimulation ofadenylate cyclase activity by various agonists in membranes from lean and obese animals
The response of adenylate cyclase in purified adipocyte plasma membranes from lean and obese mice to various agonists is shown in Table 2 . Basal activity was similar in membranes from lean and obese mice, as was the degree of stimulation by NaF (fourfold) and Gpp(NH)p (fourfold). Isoprenaline gave a significantly lower stimulation of adenylate cyclase activity in 'obese' membranes; 50 gmol/1 isoprenaline produced a fivefold stimulation in 'lean', but only a threefold stimulation in 'obese' membranes. The dose-response curves for the stimulation of adenylate cyclase by isoprenaline in membranes from lean and obese animals are illustrated in Figure 1 . Although the stimulation elicited by isoprenaline was lower in the 'obese', the concentrations of isoprenaline required to produce half-maximal and maximal stimulation were the same in 'lean' and 'obese' membranes, being 5 and 50 ~tmol/1, respectively. In the presence of Gpp(NH)p (100 l.tmol/1) the sensitivity of adenylate cyclase to isoprenaline was increased in membranes from both lean and obese animals; the concentration required to obtain half-maximal activity being reduced to 1.5 lxmol/1 in both cases. The presence of GTP did not affect the sensitivity to isoprenaline in membranes from lean animals, but reduced the sensitivity to isoprenaline in the obese, the concentration required to obtain half-maximal activity being increased to 15 lxmol/1. Dose-response curves for the stimulation of adenylate cyclase by guanine nucleotides are illustrated in Figure 2 . For stimulation by Gpp(NH)p the maximum response was similar in both groups and the concentrations required to produce half-maximal and maximal stimulation were the same in lean and obese mice (1 and 10 p~mol/1 respectively) 9 The response of adenylate cyclase to GTP was lower than the response to the nonhydrolyzable Gpp(NH)p in both 'lean' and 'obese' groups. In membranes from lean mice, the concentration of GTP required to obtain half-maximal stimulation was 0.5 lzmol/1 with maximal stimulation at 3 lxmol/1, whereas in 'obese' membranes the dose-response curve was shifted to the fight with no clear maximum stimulation even at 100 ~tmol/l GTP.
The effect of isoprenaline on the dose-response curves to guanine nucleotides was investigated. Figures 3 and 4 show comparisons of dose-response curves to Gpp(NH)p and GTP in the presence and absence of isoprenaline (50 lxmol/1). In the presence of isoprenaline, the stimulation of adenylate cyclase elicited by Gpp(NH)p was lower over the whole concentration range in membrane from obese animals (Fig. 3) . The response to Gpp(NH)p in the presence of isoprenaline was approximately additive in both cases. However, isoprenaline did not alter the concentrations of Gpp(NH)p required to obtain half-maximal or maximal stimulation in 'lean' or 'obese' preparations (1 and 10 lzmol/1 respectively). The stimulation of adenylate cyclase by GTP in the presence of isoprenaline was lower also in membranes from obese animals (Fig. 4) . In both 'lean' and 'obese' preparations, the presence of isoprenaline and GTP together resulted in a synergistic stimulation of adenylate cyclase. In membranes from lean animals, isoprenaline did not alter the concentration of GTP required for half-maximal or maximal stimulation (0.5 and 3 ~tmol/1 respectively). By contrast, in obese animals isoprenaline caused a leftward shift in the dose-response curve to GTP; the concentrations required for half-maximal and maximal stimulation being 1.2 and 3 ~tmol/1 respectively. However, even in the presence of isoprenaline, the concentration of GTP required to give half-maximal stimulation was still higher in 'obese' than in 'lean' membranes.
Time course for the stimulation of adenylate cyclase activity by Gpp(NH)p
The time courses for stimulation of adenylate cyclase activity by Gpp(NH)p in the presence and absence of isoprenaline are shown in Figure 5 . In adipocyte plasma membranes from lean animals, stimulation by Gpp(NH)p alone was preceded by a lag period of approximately 2min; however, with membranes from obese animals, the lag period was increased to approximately 5 min. Following the lag period, the Gpp(NH)pactivated rate was similar in both cases. The presence of isoprenaline reduced the lag period prior to activation in membranes from both lean and obese animals to approximately I and 2 min, respectively. Following the reduced lag period, the presence of isoprenaline resulted in a 100% increase in the adenylate cyclase activity in membranes from lean mice, but only a 20% increase in the activity in membranes from obese mice.
The binding of 3H-dihydroalprenalol to adipocyte plasma membranes
The specific binding of the labelled fl-adrenergic ligand, 3H-dihydroalprenalol, to adipocyte plasma membranes was investigated using isoprenaline (100 ~tmol/1) as the displacing ligand. Figure 6 shows Scatchard analysis of 3H-dihydroalprenalol binding over the 0-6 nmol range. The results suggest the presence of a binding site with a dissociation constant (K4) of approximately 10nmol/1 in membranes from both lean and obese mice, but indicate a reduction in the number of binding sites (Bmax) of approximately 30% in membranes from obese animals (120fmol/mg protein in lean versus 80fmol/mg protein in obese). Because of the large number of animals required to prepare the purified membrane fraction for use in binding studies, repeat experiments were not possible.
Discussion
We have used a purified plasma membrane fraction prepared from isolated adipocytes to investigate the cause of the defect in isoprenaline stimulated adenylate cyclase activity observed in obese mice. This contrasts with previous studies in which relatively impure membrane preparations were used [1, 3, 5, 9] . Our results indicate that basal adenylate cyclase activity is similar in lean and obese mice, confirming a previous study in which a purified membrane preparation was also used [2] . These results contrast with studies using either crude membrane fractions [3, 5, 9] or fat cell ghosts [4] in which lower basal activity was reported. Despite these discrepancies, an impaired response of adenylate cyclase to fl-agonists is membranes from obese animals has been reported universally [1] [2] [3] [4] [5] 9] . This observation was confirmed in our studies in which the maximum stimulation of activity by isoprenaline was reduced by approximately 50% in obese mice. Present evidence indicates a collision coupling mechanism for the hormonal activation of adenylate cyclase in the presence of guanine nucleotides [11, 20] . Binding of hormone to its receptor initiates a transitory coupling between the hormone-receptor complex and the regulatory protein which induces a conformational change and activation of the regulatory protein by the exchange of GDP for GTR The activated regulatory protein then interacts with the catalytic unit which is in turn activated to catalyze the conversion of ATP to cy- clic AMR The rate-limiting step may be either the dissociation of GDP from the regulatory protein [21] or a slow conformational change in the regulatory protein from an inactive to an active form [22] . Fluoride ions stimulate adenylate cyclase by causing an interaction between the regulatory and catalytic components without any exchange of GDP for GTP [23] . In this study, adenylate cyclase activation by fluoride was similar in membranes from lean and obese mice, suggesting that both the coupling between the regulatory and catalytic components and the number of catalytic units was normal in obese animals.
However, this investigation has identified two clear defects in the adenylate cyclase system of white adipocytes of obese animals in the absence of isoprenaline, which suggests that an alteration in the properties of the regulatory protein may contribute towards the impaired hormonal activation. Firstly, the sensitivity of adenylate cyclase to stimulation by GTP was reduced in obese animals, although the sensitivity to non-hydrolyzable Gpp(NH)p was normal. These results conflict with those of Begin-Heick [5] , who found no differential sensitivity of the enzyme to GTP and Gpp(NH)p in 'obese' preparations in the presence or absence of isoprenaline. However, a crude membrane preparation was used in those studies, and no maximal response to GTP alone was observed in either 'lean' or 'obese' membranes. An enhanced GTPase activity or an increased availability of GTP for hydrolysis may be responsible for the impaired response in obese mice, since hydrolysis of GTP bound to the regulatory protein is associated with inactivation of the catalytic unit. However, alternative explanations, such as a defect in the guanine nucleotide binding site on the regulatory protein cannot be ruled out, particularly in the light of a second observation, that the lag period preceding activation by Gpp(NH)p alone was prolonged in obese mice, suggesting that the rate of binding of guanine nucleotides to the regulatory protein is slower in the obese state.
The 3H-dihydroalprenalol binding studies indicated a reduction in specific binding to adipocyte plasma membranes from obese mice. However, two observations suggest that it is unlikely that a 30% reduction in /3-receptor number is the only cause of the lack of potentiation of the response to guanine nucleotides by isoprenaline in obese animals. Firstly, the dose-response curve to isoprenaline in membranes from obese animals showed a decrease in maximum response. A reduction in receptor number normally would be associated with a similar maximum response but a decrease in sensitivity; no significant rightward shift in the dose-response curve to isoprenaline in obese animals was apparent in thes'e experiments, either with isoprenaline alone, or in the presence of Gpp(NH)p. Secondly, according to the collision coupling hypothesis [20] , in the presence of guanine nucleotides a single occupied receptor can interact with and activate several regulatory subunits. Therefore, in the presence of the irreversible activator 471 Gpp(NH)p, a reduced receptor number would result in a similar final extent of activation, although the rate of activation would be slower. The results of the time course study shown in Figure 5 indicate that this is not the case. Another possibility to explain the impaired potentiation of the response to guanine nucleotides by isoprenaline is a defect in the interaction between the hormone-receptor complex and the regulatory protein. Such a defect may be related directly to the alterations in guanine nucleotide binding or GTPase activity described previously, or to a more general change, for example, in the conformation of the regulatory protein.
The presence of Gpp(NH)p increased the sensitivity of adenylate cyclase to isoprenaline in both groups of mice; however, GTP had no effect on isoprenaline sensitivity in the lean, but caused a reduction in sensitivity in the obese animals. A reduction in the sensitivity of the adenylate cyclase system to isoprenaline in the presence of GTP has been described in other systems [24, 25] . Nahorski has shown that in the presence of GTP the affinity of isoprenaline binding to fl2-receptors is reduced, but the affinity of binding to flvreceptors is unchanged [26] . Begin-Heick has shown that the fl-receptors in adipocytes of obese animals are of the fl2-subtype rather than the fit-subtype [27] . Thus, the reduction in sensitivity to isoprenaline in the presence of GTP in the obese animal may reflect this difference in fl-receptor subtype.
Hormone-stimulated adenylate cyclase is sensitive to membrane fluidity and lipid composition [28] both at the level of hormone-receptor binding [29] and in the interactions between hormone-receptor, regulatory protein and catalytic unit [30] [31] [32] [33] [34] [35] . Previous studies in this laboratory have shown that adipocyte plasma membranes from obese mice are characterized by an increase in membrane fluidity and by major alterations of membrane phospholipid fatty acyl composition which were particularly prominent in phosphatidylethanolamine [9, 10] . When membrane fluidity was reduced in obese mice by housing at 34 ~ an increase in the response of adenylate cyclase to isoprenaline was observed [9] . It is thus possible that the regulatory changes in the adenylate cyclase system which are observed in the obese mouse are secondary to the changes in membrane lipid composition.
